<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Mounjaro on Foundation Wellness | TRT, Hormones &amp; Weight Loss, Utah</title><link>https://foundationmedicalwellness.com/tags/mounjaro/</link><description>Recent content in Mounjaro on Foundation Wellness | TRT, Hormones &amp; Weight Loss, Utah</description><generator>Hugo</generator><language>en-us</language><copyright>Foundation Wellness. All rights reserved.</copyright><lastBuildDate>Thu, 10 Sep 2026 00:00:00 +0000</lastBuildDate><atom:link href="https://foundationmedicalwellness.com/tags/mounjaro/index.xml" rel="self" type="application/rss+xml"/><item><title>Tirzepatide Side Effects: FDA Rates at Every Dose Level</title><link>https://foundationmedicalwellness.com/tirzepatide-side-effects/</link><pubDate>Thu, 10 Sep 2026 00:00:00 +0000</pubDate><guid>https://foundationmedicalwellness.com/tirzepatide-side-effects/</guid><description>&lt;p>Tirzepatide side effects are mostly digestive, and they cluster around dose increases. In the Zepbound weight trials, nausea reached 28% at 15 mg against 8% on placebo. Diarrhea hit 23%, vomiting 13%. Serious problems are uncommon, but a few deserve a same-day phone call.&lt;/p>
&lt;p>&lt;img src="https://foundationmedicalwellness.com/images/blog/tirzepatide-side-effects/tirzepatide-side-effects-infographic.webp" alt="Tirzepatide side effects by dose at a glance">&lt;/p>
&lt;h2 id="what-are-the-most-common-tirzepatide-side-effects">What Are the Most Common Tirzepatide Side Effects?&lt;/h2>
&lt;p>Tirzepatide is a dual GIP and GLP-1 receptor agonist. Not a GLP-1. That&amp;rsquo;s a real distinction, not a technicality, and it&amp;rsquo;s the correction we make most often in the exam room. Tirzepatide acts on two gut hormone receptors rather than one, and both of those pathways slow the stomach down. Slower stomach emptying is where nearly every common side effect starts.&lt;/p></description></item></channel></rss>